Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05462873
Title A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
University of California LA Los Angeles California 90095 United States Details
Florida Cancer Specialists Fort Myers Florida 33901 United States Details
Massachusetts General Hospital Dept. of Mass General Hospital Boston Massachusetts 02114 United States Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field